ResearcherKagawa UniversityActive in the last 2 years
Ayaka Shimomura
Matched on OpenAlex author ID A5081010938. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers
Papers 4
- Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002304↗
- Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.17151↗
- Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer. Co-author DOI 10.1093/jjco/hyac074↗
- Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.09.006↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keiichi Okano · 4 shared papers, 2021–2024 · strength 0.58
- Paper Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.17151↗
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Hironobu Suto · 3 shared papers, 2022–2024 · strength 0.47
- Paper Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.17151↗
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Minoru Oshima · 3 shared papers, 2022–2024 · strength 0.47
- Paper Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.17151↗
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Mina Nagao · 3 shared papers, 2022–2024 · strength 0.47
- Paper Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.17151↗
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Yukiko Wada · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Tsutomu Masaki · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Yasuyuki Suzuki · 2 shared papers, 2021–2022 · strength 0.22
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074↗
- Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
- Takashi Norikane · 1 shared paper, 2024 · strength 0.18
- Ai Kameyama · 1 shared paper, 2021 · strength 0.10
- Keiko Yamakawa · 1 shared paper, 2021 · strength 0.10
- Mutsuo Furihata · 1 shared paper, 2021 · strength 0.10
- Yoko Matsuda · 1 shared paper, 2021 · strength 0.10
- Juanjuan Ye · 1 shared paper, 2021 · strength 0.10
- Motohiro Kojima · 1 shared paper, 2021 · strength 0.10
- Masanao Yokohira · 1 shared paper, 2021 · strength 0.10
- Mari A. Mino-Kenudson · 1 shared paper, 2021 · strength 0.10
- Chiharu Tanaka · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.